Form 8-K - Current report:
SEC Accession No. 0001193125-21-326070
Filing Date
2021-11-10
Accepted
2021-11-10 16:31:20
Documents
23
Period of Report
2021-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d249996d8k.htm   iXBRL 8-K 44827
2 EX-4.2 d249996dex42.htm EX-4.2 344726
3 EX-4.6 d249996dex46.htm EX-4.6 340778
4 EX-5.1 d249996dex51.htm EX-5.1 14712
5 EX-5.2 d249996dex52.htm EX-5.2 14488
6 EX-5.3 d249996dex53.htm EX-5.3 44680
10 GRAPHIC g249996dsp007.jpg GRAPHIC 130000
11 GRAPHIC g249996dsp008.jpg GRAPHIC 14713
12 GRAPHIC g249996g1110032904013.jpg GRAPHIC 3904
13 GRAPHIC g249996g1110032904357.jpg GRAPHIC 2082
14 GRAPHIC g249996snap0001.jpg GRAPHIC 3878
15 GRAPHIC g249996snap0002.jpg GRAPHIC 2480
  Complete submission text file 0001193125-21-326070.txt   1310203

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA teva-20211109.xsd EX-101.SCH 2895
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20211109_lab.xml EX-101.LAB 17306
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20211109_pre.xml EX-101.PRE 10931
16 EXTRACTED XBRL INSTANCE DOCUMENT d249996d8k_htm.xml XML 3422
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 211397170
SIC: 2834 Pharmaceutical Preparations